These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000121-30 An Open Label Pilot study with oral fludarabine, oral cyclophosphamide and CAMPATH 1H (FCC) for patients with refractory or Relapsed B cells Chronic Lynphocytic Leukaemia 2013-08-02 due-trials
Completed, but no date 2007-004358-10 EVALUATION OF THE TOLERABILITY AND EFFICACY OF ERYTHROPOIETIN (EPO) TREATMENT IN SPINAL SHOCK: COMPARATIVE STUDY VS METHYLPREDNISOLONE (MP) bad-data
Completed, but no date 2007-004370-55 Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial bad-data
Completed, but no date 2007-004512-32 SYNTHESIS: A RANDOMIZED CONTROLLED TRIAL ON INTRA-ARTERIAL VERSUS INTRAVENOUS bad-data
Ongoing 2007-005831-27 Use of rHuEpo before autologous hematopoietic stem cell transplantation in patients affected by multiple myeloma, non Hodgkin disease and breast cancer to reduce transfusional requirement after myeloa... not-yet-due
Completed, but no date 2007-007007-32 Efficacy of IVIG in the treatment of treatment-resistent painful neuropathy bad-data
Not reported 2008-000561-28 Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. 2009-10-15 due-trials
Completed, but no date 2008-003666-26 A double-blind, randomized trial of ARNICA comp.-Heel treatment in patients undergoing hemorrhoidectomy in day surgery: evaluation of postoperative pain bad-data
Not reported 2009-014769-16 REWORD-HF REverse WOrsening Renal function in Decompensated Heart Failure Impact of different therapeutic approaches in patients with cardiorenal syndrome in the setting of acute decompensated cong... 2013-06-20 due-trials
Not reported 2009-016958-41 Early LEvosimendan Vs usual care in Advanced chronic hearT failurE 2014-05-31 due-trials
Ongoing 2010-018353-36 BeTACTIC Study. Best Therapy After Cardiac Transplantation, the Italian Challenge. A multicenter, prospective, randomized, open-label study to compare the efficacy and safety of Everolimus and Mycoph... not-yet-due
Reported results 2010-022332-37 A SINGLE-ARM MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA 2015-11-18 due-trials
Completed, but no date 2010-023883-42 Randomized, double-blind, placebo controlled trial to evaluate the efficacy of high dose intravenous immunoglobulins in diabetic painful polyneuropaty (DPNP)resistant to conventional therapies bad-data
Completed, but no date 2011-002080-21 Open-label phase 2 study of dacarbazine in patients with metastatic colorectal carcinoma based on expression of O6-methylguanine-DNA-methyltransferase (MGMT) bad-data
Completed, but no date 2012-003338-17 Phase II study of temozolomide in metastatic colorectal cancer patients resistant to standard therapies and with O6-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation bad-data
Ongoing 2012-004118-33 High-dose cyclophosphamide role in the prophylaxis of GVHD in elderly patients (66-70 years) with acute leukemia or myelodysplasia high-risk, submitted to allogenic transplant of peripheral hematopoie... not-yet-due
Ongoing 2012-005062-34 An open label, single arm, phase II study of nilotinib 300 mg BID in newly diagnosed not-yet-due
Ongoing 2014-002672-86 PHASE II CLINICAL TRIAL FOR A STEPWISE PROGRESSION IN THE TREATMENT OF CARDIOGENIC SHOCK not-yet-due